Johnny John - 04 Apr 2022 Form 3/A - Amendment Insider Report for DELCATH SYSTEMS, INC. (DCTH)

Role: Senior Vice President Clinical Development and Medical Affairs
Signature: /s/ Johnny John
Issuer symbol: DCTH
Transactions as of: 04 Apr 2022
Net transactions value: $0
Form type: 3/A - Amendment
Filing time: 15 Aug 2022, 12:06:48 UTC
Date Of Original Report: 11 Apr 2022
Next filing: 26 Jan 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	DCTH	Stock Option (right to buy)							04 Apr 2022	Common Stock	38,499	$7.14	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option shares will vest and become exercisable in equal monthly installments over the 36-month period beginning on the grant date (1/36th will vest on the first day of each month during said 36-month period, with the first vesting date being March 1, 2022) for so long as the reporting person remains an employee of the issuer (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan).

Content

The option shares will vest and become exercisable in equal monthly installments over the 36-month period beginning on the grant date (1/36th will vest on the first day of each month during said 36-month period, with the first vesting date being March 1, 2022) for so long as the reporting person remains an employee of the issuer (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan).

Remarks:

Senior Vice President Clinical Development and Medical Affairs